The American College of Cardiology (ACC) has recognized Virtua Our Lady of Lourdes Hospital for its expertise and commitment to high-quality care for patients undergoing transcatheter valve repair and replacement procedures. The hospital earned Transcatheter Valve Certification in December 2025 following a comprehensive evaluation of its multidisciplinary team structure, formalized training processes, shared decision-making practices, and performance in national clinical registries.
“Virtua Our Lady of Lourdes Hospital has demonstrated its commitment to providing Southern New Jersey with excellent heart care,” said Deepak L. Bhatt, MD, MPH, FACC, chair of the ACC Accreditation Management Board. “ACC Accreditation Services is proud to award Virtua Our Lady of Lourdes Hospital with Transcatheter Valve Certification.”
Virtua’s Structural Heart Program, based out of its Camden hospital, offers leading-edge treatments for abnormalities or defects affecting the heart’s walls, chambers, and valves—helping restore healthy function and enhance quality of life. Virtua’s cardiac specialists are at the forefront of structural heart care, performing groundbreaking, first-of-their-kind valve procedures that save lives.
Most treatments employ minimally invasive techniques, which reduce hospital stays and facilitate a faster, more comfortable recovery. Additionally, Virtua specialists are deeply involved in clinical trials, providing patients with access to advanced, innovative care close to home.
“We are proud to offer leading-edge transcatheter valve therapies that improve both quality of life and long-term outcomes for our patients,” said Ibrahim A. Moussa, DO, medical director of the Structural Heart Program at Virtua Our Lady of Lourdes Hospital. “This certification is a testament to the expertise of our multidisciplinary team and the rigorous standards we uphold every day,”
The ACC provides U.S. and international hospitals—including Virtua Our Lady of Lourdes Hospital—with a comprehensive suite of cardiac accreditation services designed to enhance patient outcomes and support operational performance. These services span the full spectrum of cardiac care, including transcatheter valve therapies.
The ACC’s Transcatheter Valve Certification is an external review program that works in tandem with established national clinical databases to monitor patient safety and real-world outcomes related to transcatheter valve therapies. Participation in databases such as the STS/ACC TVT Registry is a requirement for hospitals seeking this designation.
This certification relies on national clinical measures to guide care decisions and connects process improvement efforts directly to patient outcomes. Hospitals that achieve Transcatheter Valve Certification gain access to best practices in evidence-based medicine, strengthen patient-centered decision-making, and track key performance metrics to identify opportunities for continued improvement.
About the American College of Cardiology
The American College of Cardiology (ACC) is the global leader in transforming cardiovascular care and improving heart health for all. As the preeminent source of professional medical education for the entire cardiovascular care team since 1949, ACC credentials cardiovascular professionals in over 140 countries who meet stringent qualifications and leads in the formation of health policy, standards and guidelines. Through its world-renowned family of JACC Journals, NCDR registries, ACC Accreditation Services, global network of Member Sections, CardioSmart patient resources and more, the College is committed to ensuring a world where science, knowledge and innovation optimize patient care and outcomes. Learn more at acc.org or follow @ACCinTouch.